Clark, Otavio http://orcid.org/0000-0003-1607-2589
Sarmento, Tulio
Eccleston, Anthony
Brinkmann, Julia
Picoli, Renato
Daliparthi, Vamsi
Voss, Jorine
Chandrasekar, Sanjana
Thompson, Allison
Chang, Jane
Funding for this research was provided by:
Pfizer
Article History
Accepted: 15 July 2024
First Online: 18 August 2024
Declarations
:
: Not applicable, as only secondary data were used.
: Not applicable, as only secondary data were used.
: Not applicable, as only secondary data were used.
: Code was not made available.
: This study was sponsored by Pfizer. Oracle Company conducted the study and was responsible for validating and storing the data.
: O.C., T.S., R.P., V.D., and J.V. are or were employees of Oracle, which was a paid consultant to Pfizer in connection with the development of this manuscript. A.E., J.B., S.C., A.T., and J.C. are employees of Pfizer, the sponsor of this study.
: All authors contributed to the study design and concept, data analysis and review, data interpretation, and manuscript review.
: In Supplementary Material we list the data sources used and the respective prices of drugs, medical procedures, etc. The raw model data are not made available.